Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
RSC Adv ; 12(41): 26673-26679, 2022 Sep 16.
Article de Anglais | MEDLINE | ID: mdl-36275146

RÉSUMÉ

The reaction between O-acetyl oximes and ß-ketoesters/nitriles catalyzed by copper generated polysubstituted pyrroles and furans, respectively, under redox-neutral reaction conditions. Using this protocol, pyrroles or furans could be obtained simply by choosing an appropriate active methylene compound. Although both transformations occur essentially under the same reaction conditions, control experiments indicated that they follow different mechanistic pathways.

2.
Org Biomol Chem ; 19(38): 8272-8280, 2021 10 06.
Article de Anglais | MEDLINE | ID: mdl-34518856

RÉSUMÉ

A high-yielding total synthesis of the indole alkaloid prenostodione was completed in 4 steps and 44% overall yield from 1H-indole-3-carboxylic acid. The expedient syntheses of prenostodiones containing distinct substituents at the para position of the phenyl frame underscored the scope of this methodology. The cytotoxic activities of the tert-butyl esters of prenostodione analogues were tested using six tumor cell lines. Preliminary structure-activity studies revealed the importance of the identity of the aromatic substituent at the C-4 position for cytotoxic activity. The IC50 values of these compounds were found to compare satisfactorily with those of the commercially available drugs etoposide and cisplatin. Furthermore, the compounds with, respectively, -OMe (14d) and -NO2 (14f) groups at C-4 were more selective than these control compounds in PC-3, K-562, and MCF-7 cells. Also, computational studies were carried out to determine the ADMET profiles and passive membrane permeabilities of the compounds. The results suggested the promise of 14d and 14f as hit compounds for the development of new anticancer agents.


Sujet(s)
Indoles
3.
Drug Dev Res ; 81(3): 350-355, 2020 05.
Article de Anglais | MEDLINE | ID: mdl-31777976

RÉSUMÉ

Acylthiosemicarbazides 8a-n were designed by structural modification of lead Compound 7. The syntheses of 8a-n involve a five-step procedure starting from carboxylic acids. Compounds 8a-n were tested against three Mycobacterium tuberculosis strains to measure their inhibitory antituberculosis activities. These activities could be explained according to the presence or absence of the chlorine substituent in the aromatic ring of the amide joined to the thiosemicarbazide core. Thiosemicarbazide derivative 8n is a candidate for the development of novel antitubercular agents. Ongoing studies are focused on exploring the mechanism by which these compounds inhibit M. tuberculosis cell growth.


Sujet(s)
Antituberculeux/pharmacologie , Mycobacterium tuberculosis/effets des médicaments et des substances chimiques , Semicarbazides/pharmacologie , Animaux , Antituberculeux/synthèse chimique , Antituberculeux/composition chimique , Chlorocebus aethiops , Semicarbazides/synthèse chimique , Semicarbazides/composition chimique , Relation structure-activité , Cellules Vero
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE